Nové postupy v antikoagulační léčbě u seniorů s fibrilací síní
| Title in English | New approaches in anticoagulant therapy in elderly patients with atrial fibrillation |
|---|---|
| Authors | |
| Year of publication | 2012 |
| Type | Article in Periodical |
| Magazine / Source | Kardiologická revue |
| MU Faculty or unit | |
| Citation | |
| Field | Cardiovascular diseases incl. cardiosurgery |
| Keywords | anticoagulation treatment; atrial fibrillation; warfarin; gatrans; xabans |
| Description | New approaches to anticoagulant treatment for senior citizens with atrial fibrillation. Anticoagulant treatment for senior citizens with atrial fibrillation represents one of the most frequently administered treatments, with a relatively safe risk profile. Before beginning the procedure, it is necessary to carry out a risk assessment to assist the selection of a suitable therapy and in assessment of the risk of side-effects (bleeding). Until recently, the only anticoagulant was warfarin, which has a number of shortcomings. In recent years, a number of anticoagulant substances have appeared that block the functioning of thrombin or factor X, and which have shown in a number of clinical tests greater effectiveness in the prevenbon of thromboses connected to lower prevalence of bleeding. New anticoagulants have not only a number of advantages, but also some limitations that must be respected during treatment so that the benefits of new substances are not negated through incorrect use in practice. |
| Related projects: |